To access this content, a subscription to Bankruptcy Authority is required.
Track this case
Case overview
4:23-cv-04147
Texas Southern
Other Statutory Actions
Andrew S Hanen
A Texas federal magistrate on Monday advised against dismissing Pacira Biosciences Inc.'s suit against a rival, finding that Pacira had alleged enough facts to show QuVa Pharma Inc.'s advertising is deceptive in a suit over the former company's compounded drug for pain.
Pharmaceutical company Pacira BioSciences Inc. is looking to stop rivals from marketing their so-called generic versions of its non-opioid based drug used to manage post-surgery pain, claiming in three separate lawsuits that the companies falsely advertise their medications as qualifying for an exemption to federal regulatory approval.